Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Critical Care Admission of an HIV Patient with Diabetic Ketoacidosis Secondary to Pembrolizumab
ArticleAbstract: Background. Pembrolizumab is a checkpoint inhibitor that targets the programmed cell death-1 receptoPalabras claves:Autores:Botz G.H., John A. Cuenca, Laserna A., Nates J.L., Reyes M.P.Fuentes:scopusOutcomes and Pbkp_redictors of 28-Day Mortality in Patients With Hematologic Malignancies and Septic Shock Defined by Sepsis-3 Criteria
ArticleAbstract: Background: To describe short-term outcomes and independent pbkp_redictors of 28-dayx mortality in aPalabras claves:Autores:Gutierrez C., Heatter A.J., Hernandez M., John A. Cuenca, Manjappachar N.K., Martin P.R., Nates J.L., Price K.J., Ramirez C.M., Rathi N., Reyes M.P., Sprung C.L.Fuentes:scopusTribulations of conducting critically ill cancer patients research: Lessons from a failed septic shock trial and Murphy's law
ArticleAbstract:Palabras claves:Autores:Heatter J., John A. Cuenca, Martin P.R., Nates J.L., Reyes M.P., Villalobos D.H.D.Fuentes:scopus